Literature DB >> 33131014

Prognostic stratification in septic patients with overt and cryptic shock by speckle tracking echocardiography.

Francesca Innocenti1, Vittorio Palmieri2, Valerio Teodoro Stefanone3, Federico D'Argenzio3, Marco Cigana3, Michele Montuori3, Elisa Capretti3, Anna De Paris3, Stefano Calcagno3, Irene Tassinari3, Riccardo Pini3.   

Abstract

We evaluated the prevalence and prognostic value of left (LV) and right (RV) ventricular systolic dysfunction in the presence of overt and cryptic shock. In this prospective study, between October 2012 and June 2019, we enrolled 354 patients with sepsis, 41% with shock, among those admitted to the Emergency Department High-Dependency Unit. Patients were grouped based on the presence of shock, or by the presence of lactate levels ≥ (LAC +) or < 2 mmol/L (LAC-) evaluated within the first 24 h. By echocardiography performed within 24 h from the admission, LV systolic dysfunction was defined as global longitudinal strain (GLS) > -14%; RV systolic dysfunction as Tricuspid Annular Plane Systolic Excursion (TAPSE) < 16 mm. All-cause mortality was assessed at day-7 and day-28 follow-up. Mean values of LV GLS (-12.3 ± 3.4 vs -12.9 ± 3.8%) and TAPSE (1.8 ± 0.7 vs 1.8 ± 0.5 cm, all p = NS) were similar in patients with and in those without shock. LV GLS was significantly worse in LAC + than LAC- patients (- 11.2 ± 3.1 vs - 12.9 ± 3.7%, p = 0.001). In patients without shock, as well as in those LAC-, LV dysfunction was associated with increased day-28 mortality rate (78% vs 57% in non-survivors and survivors without shock and 74% vs 53% in non-survivors and survivors LAC-, all p < 0.01). LV (RR 2.26, 95% CI 1.37-3.74) and RV systolic dysfunction (RR 1.85, 95% CI 1.22-2.81) were associated with increased 28-day mortality rate in addition and independent to LAC + (RR 1.81, 95% CI 1.15-2.84). In conclusion, LV and RV ventricular dysfunction were independently associated with an increased mortality rate, altogether with the presence of cryptic shock.

Entities:  

Keywords:  Lactate levels; Prognosis; Septic shock; Systolic dysfunction

Mesh:

Year:  2020        PMID: 33131014     DOI: 10.1007/s11739-020-02545-3

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  28 in total

1.  Quantitative assessment of the microcirculation in healthy volunteers and in patients with septic shock.

Authors:  Vanina S Kanoore Edul; Carolina Enrico; Bruno Laviolle; Alejandro Risso Vazquez; Can Ince; Arnaldo Dubin
Journal:  Crit Care Med       Date:  2012-05       Impact factor: 7.598

2.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

3.  Microcirculatory alterations in traumatic hemorrhagic shock.

Authors:  Guillaume Tachon; Anatole Harrois; Sebastien Tanaka; Hiromi Kato; Olivier Huet; Julien Pottecher; Eric Vicaut; Jacques Duranteau
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

Review 4.  Spectrum of cardiovascular function during gram-negative sepsis.

Authors:  M L Hess; A Hastillo; L J Greenfield
Journal:  Prog Cardiovasc Dis       Date:  1981 Jan-Feb       Impact factor: 8.194

5.  Persistent preload defect in severe sepsis despite fluid loading: A longitudinal echocardiographic study in patients with septic shock.

Authors:  F Jardin; T Fourme; B Page; Y Loubières; A Vieillard-Baron; A Beauchet; J P Bourdarias
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

6.  Microvascular perfusion as a target for fluid resuscitation in experimental circulatory shock.

Authors:  Michel Egide van Genderen; Eva Klijn; Alexandre Lima; Jeroen de Jonge; Steven Sleeswijk Visser; Jacqueline Voorbeijtel; Jan Bakker; Jasper van Bommel
Journal:  Crit Care Med       Date:  2014-02       Impact factor: 7.598

7.  Persistent villi hypoperfusion explains intramucosal acidosis in sheep endotoxemia.

Authors:  Arnaldo Dubin; Vanina Siham Kanoore Edul; Mario Omar Pozo; Gastón Murias; Carlos Manuel Canullán; Enrique Francisco Martins; Gonzalo Ferrara; Héctor Saul Canales; Mercedes Laporte; Elisa Estenssoro; Can Ince
Journal:  Crit Care Med       Date:  2008-02       Impact factor: 7.598

Review 8.  Lactate levels and hemodynamic coherence in acute circulatory failure.

Authors:  Jan Bakker
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2016-11-10

9.  The role of renal hypoperfusion in development of renal microcirculatory dysfunction in endotoxemic rats.

Authors:  Matthieu Legrand; Rick Bezemer; Asli Kandil; Cihan Demirci; Didier Payen; Can Ince
Journal:  Intensive Care Med       Date:  2011-06-22       Impact factor: 17.440

Review 10.  The value of blood lactate kinetics in critically ill patients: a systematic review.

Authors:  Jean-Louis Vincent; Amanda Quintairos E Silva; Lúcio Couto; Fabio S Taccone
Journal:  Crit Care       Date:  2016-08-13       Impact factor: 9.097

View more
  3 in total

1.  Speckle-tracking echocardiography for detecting myocardial dysfunction in sepsis and septic shock patients: A single emergency department study.

Authors:  Xuan Fu; Xue Lin; Samuel Seery; Li-Na Zhao; Hua-Dong Zhu; Jun Xu; Xue-Zhong Yu
Journal:  World J Emerg Med       Date:  2022

2.  Construction of a predictive model and prognosis of left ventricular systolic dysfunction in patients with sepsis based on the diagnosis using left ventricular global longitudinal strain.

Authors:  Jiangquan Yu; Ruiqiang Zheng; Penglei Yang; Daxin Wang
Journal:  J Intensive Care       Date:  2022-06-15

3.  Predialysis serum lactate levels could predict dialysis withdrawal in Type 1 cardiorenal syndrome patients.

Authors:  Heng-Chih Pan; Tao-Min Huang; Chiao-Yin Sun; Nai-Kuan Chou; Chun-Hao Tsao; Fang-Yu Yeh; Tai-Shuan Lai; Yung-Ming Chen; Vin-Cent Wu
Journal:  EClinicalMedicine       Date:  2022-01-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.